Comments on: Tersan’s AI provides evidence for 3 years clinical efficacy of ANAVEX®2-73 Alzheimer’s targeted therapy @CTAD2018

Comments on: Tersan’s AI provides evidence for 3 years clinical efficacy of ANAVEX®2-73 Alzheimer’s targeted therapy @CTAD2018 https://www.tersanpharm.com/arianas-ai-provides-evidence-for-3-years-clinical-efficacy-of-anavex2-73-alzheimers-targeted-therapy-ctad2018/?utm_source=rss&utm_medium=rss&utm_campaign=arianas-ai-provides-evidence-for-3-years-clinical-efficacy-of-anavex2-73-alzheimers-targeted-therapy-ctad2018 The AI DRUG Development Company Tue, 14 Dec 2021 21:23:04 +0000 hourly 1 https://wordpress.org/?v=5.8.2